DigestRedComo funciona
Red
/
Empresas
Ep
No verificado

Epicrispr Biotechnologies

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

13 Comunicados de prensa

Ver todos los comunicados de prensa
11/08/2026
Industria
Higiene alimentaria
Sanidad
Finanzas
Farmacéutica
Asociaciones/Profesionales
Biotecnología
Infancia
Medicina - Varios
Familia
Ciencia
Ir de compras
Salud
Epicrispr Biotechnologies Closes $90 Million Oversubscribed Series C Financing to Advance First-in-Class Epigenetic Therapy Toward Pivotal Studies in FSHD
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
07/07/2026
Eventos
Industria
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Epicrispr Completes Enrollment and Dose Escalation in First-in-Human EPI-321 Trial for FSHD
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
27/06/2026
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
26/06/2026
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
24/03/2026
Epicrispr Biotechnologies Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
08/01/2026
Eventos
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
08/12/2025
Eventos
Web y redes sociales
Asociaciones/Profesionales
Salud
Finanzas
Medicina - Varios
Farmacéutica
Biotecnología
Epicrispr Biotechnologies to Present at 44th Annual J.P. Morgan Healthcare Conference
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
05/08/2025
Sanidad
Ciencia
Farmacéutica
Ir de compras
Biotecnología
Infancia
Medicina - Varios
Higiene alimentaria
Salud
Industria
Epicrispr Biotechnologies Doses First Patient in First-in-Human Clinical Trial of EPI-321 for Facioscapulohumeral Muscular Dystrophy
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
12/05/2025
Eventos
Ciencia
Biotecnología
Farmacéutica
Salud
Epicrispr Biotechnologies Named Finalist in XPRIZE Healthspan Competition FSHD Bonus Prize
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0
05/05/2025
Eventos
Biotecnología
Higiene alimentaria
Sanidad
Salud
Farmacéutica
Ciencia
Medicina - Varios
Epicrispr Biotechnologies Announces Five Presentations Highlighting Advances in Epigenetic Modulation and AAV Manufacturing at ASGCT 2025 Annual Meeting
Fuente
Epicrispr Biotechnologies
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0